When was Paragon Intellectual Properties founded?
Paragon Intellectual Properties was founded in 2004.
What is Paragon Intellectual Properties's latest funding round?
Paragon Intellectual Properties's latest funding round is Other Investors.
Who are the investors of Paragon Intellectual Properties?
Investors of Paragon Intellectual Properties include SurModics.
Who are Paragon Intellectual Properties's competitors?
Competitors of Paragon Intellectual Properties include Sonivate Medical, Aethlon Medical, HistoSonics, Mercator MedSystems, Intercure and 11 more.
You May Also Like
Cardiogenesis is a medical device company committed to innovating tools for the treatment of cardiovascular disease. The company, located in Orange County, California, is a provider in laser revascularization and angiogenic therapies for the treatment of severe angina.
Vascure is a medical device company. The company is developing an therapeutic device for percutaneous treatment of arterial disease. Vascure's system will offer a one-stop solution for restoring blood flow to narrowed or occluded blood vessels in a range of clinical conditions, including heavily calcified lesions. Vascure will provide Intervantionalists with a safe and easy to use device, shortening procedure time, allowing percutaneous treatment in cases previously requiring radical surgical procedures and generating improved clinical outcomes.
HistoSonics develops a device that uses ultrasound pulses to treat prostate disease. The device is a non-invasive soft tissue ablation modality that mechanically homogenizes target tissue resulting in complete cellular destruction. As a non-thermal modality, histotripsy ablates tissue with no thermal injury. The liquefied tissue is absorbed or voided without remnants or scarring.
ADVOS is a combined multi-organ support system for liver, lung, kidney, and acid-base balance. Based on the principle of albumin dialysis, ADVOS allows both extracorporeal elimination of CO2, hepatic toxins, and water-soluble & protein-bound nephrotoxins, as well as the correction of metabolic and respiratory acidosis. The ADVOS procedure works with dialysis-usual access and flow rates and does not require a gas exchanger for CO2 elimination.
Aethlon Medical is the developer of the Hemopurifier - medical device that aims to treat infectious disease.
Magneceutical Health is in the Complementary and Alternative Medicine market, and is dedicated to helping people improve their health and wellness by enhancing relaxation through the use of natural and holistic magnetic fields.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.